| Application | Nootropic |
|---|---|
| CAS | 110958-19-5 |
| Molar Mass | 196.25 g/mol |
| Chemical Formula | C10H16N2O2 |
| IUPAC Name | (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one |
| Synonyms | Fasoracetam, 110958-19-5, N-(5-Oxo-D-prolyl)piperidine, NS 105 |
| Storage | Store at room temperature, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in PEG400 |
| Organoleptic Profile | White Powder |
| Physical Form | Powder |
| Specification | Purity 99%+. Chemical analysis available on request. |
Fasoracetam – Powder (2g)
$36.99
✓ High quality reference material
✓ Contains 2g per jar
147 in stock (can be backordered)
Buy Fasoracetam | ADHD candidate | Read more:
Background
Fasoracetam is a member of the racetam family that was designed first to treat vascular dementia and later ADHD.[1] It is unique from other candidates that are primarily dopaminergic and acts on mGluRs.[1] The results were positive for ADHD at 100mg+, but negative for vascular dementia.[1] Still, mGluR mutations affect a significant portion of ADHD sufferers, making Fasoracetam a very targeted treatment.[1] One rodent study suggests upregulation of GABAB receptors is responsible for its antidepressant effects.[3] We hope to encourage research by allowing researchers to buy Fasoracetam.
Pharmacokinetics
Fasoracetam’s oral bioavailability is 79-97%, meaning it is very well absorbed.[2]
References
[1] Fasoracetam as a treatment for ADHD: https://www.nature.com/articles/s41467-017-02244-2
[2] Fasoracetam’s pharmacokinetics: https://link.springer.com/article/10.2165/11319230-000000000-00000
[3] Fasoracetam’s actions at GABAB: https://pubmed.ncbi.nlm.nih.gov/9424016/
Disclaimer
Scientific discussion is purely for educational purposes. This is not medical advice.
